Error loading page.
Try refreshing the page. If that doesn't work, there may be a network issue, and you can use our self test page to see what's preventing the page from loading.
Learn more about possible network issues or contact support for more help.

Bad Blood

ebook
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranosone of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close.
“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review


In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.

Expand title description text
Publisher: Knopf Doubleday Publishing Group

Kindle Book

  • ISBN: 9781524731663
  • Release date: May 21, 2018

OverDrive Read

  • ISBN: 9781524731663
  • File size: 889 KB
  • Release date: May 21, 2018

EPUB ebook

  • ISBN: 9781524731663
  • File size: 11660 KB
  • Release date: May 21, 2018

Loading
Loading

Formats

Kindle Book
OverDrive Read
EPUB ebook

Languages

English

NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranosone of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close.
“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review


In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.

Expand title description text
Check out what's being checked out right now Wisconsin's Digital Library is a project of the Wisconsin Public Library Consortium (WPLC), with funding from Wisconsin Public Libraries and Public Library Systems. Additional support is provided by Library Services and Technology Act (LSTA) funds awarded to the Wisconsin Department of Public Instruction by the Federal Institute of Museum and Library Services